Food Nutr Res. 2016 Apr 07;60:30864. doi: 10.3402/fnr.v60.30864. eCollection 2016.
Therapeutic efficacy of ethanolic extract of Aerva javanica aerial parts in the amelioration of CCl4-induced hepatotoxicity and oxidative damage in rats.
Food & nutrition research
Ahmed H Arbab, Mohammad K Parvez, Mohammed S Al-Dosari, Adnan J Al-Rehaily, Khalid E Ibrahim, Perwez Alam, Mansour S Alsaid, Syed Rafatullah
Affiliations
Affiliations
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; [email protected].
- Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
- Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
PMID: 27059702
PMCID: PMC4826463 DOI: 10.3402/fnr.v60.30864
Abstract
BACKGROUND: Liver diseases, the fifth most common cause of global death, can be metabolic, toxin-induced, or infective. Though approximately 35 Saudi medicinal plants are traditionally used to treat liver disorders, the hepatoprotective potential of Aerva javanica has not been explored.
OBJECTIVE: To investigate the antioxidative and hepatoprotective effect of Aerva javanica.
DESIGN: Total ethanol extract of A. javanica aerial parts was prepared and tested on DCFH-toxicated HepG2 cells ex vivo, and in CCl4-injured Wistar rats in vivo. MTT assay was used to determine cell viability and the serum biochemical markers of liver injury as well as histopathology was performed. In vitro 1,1-diphenyl-2-picrylhydrazyl and β-carotene free-radical scavenging assay and phytochemical screening of the extract were done. Furthermore, A. javanica total extract was standardized and validated by high-performance thin layer chromatographic method.
RESULTS: MTT assay showed that, while DCFH-injured cells were recovered to ~56.7% by 100 µg/ml of the extract, a 200 µg/ml dose resulted in hepatocytes recovery by ~90.2%. Oral administration of the extract (100 and 200 mg/kg.bw/day) significantly normalized the serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase, gamma-glutamyl transferase, alkaline phosphatase, bilirubin, cholesterol, high-density lipoprotein, low-density lipoprotein, very-low-density lipoprotein, triglyceride, and malondialdehyde levels, including tissue nonprotein sulfhydryl and total protein in CCl4-injured rats. In addition, the histopathology of dissected liver also revealed that A. javanica cured the tissue lesion compared to silymarin treatment. In vitro assays revealed strong free-radical scavenging ability of the extract and presence of alkaloids, flavonoids, tannins, sterols, and saponins where rutin, a well-known antioxidant flavonoid, was identified.
CONCLUSIONS: Our findings demonstrate the potential of A. javanica in the attenuation of ex vivo and in vivo hepatotoxicity and oxidative damage. This further suggests its therapeutic value in various liver diseases. However, isolations of the active principles, their mechanisms of action, and other therapeutic contributions remain to be addressed.
Keywords: Aerva javanica; CCl4; DCFH; hepatoprotection; liver diseases; oxidative stress; rutin
References
- J Clin Med Res. 2009 Aug;1(3):150-7 - PubMed
- Biomed Environ Sci. 2013 Mar;26(3):209-21 - PubMed
- Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S44-8 - PubMed
- Saudi Pharm J. 2013 Apr;21(2):143-52 - PubMed
- Food Chem Toxicol. 2012 May;50(5):1568-75 - PubMed
- Biol Pharm Bull. 2005 Jan;28(1):19-23 - PubMed
- Pak J Pharm Sci. 2015 Nov;28(6 Suppl):2213-20 - PubMed
- Cell Biochem Funct. 2005 May-Jun;23 (3):169-74 - PubMed
- J Food Sci. 2012 Jul;77(7):T124-30 - PubMed
- Pak J Pharm Sci. 2012 Jul;25(3):565-9 - PubMed
- Biomedicine. 1973 Jan 20;19(1):16-9 - PubMed
- Anal Biochem. 1968 Oct 24;25(1):192-205 - PubMed
- J Sci Food Agric. 2012 May;92 (7):1441-7 - PubMed
- Fitoterapia. 2001 Mar;72(3):272-7 - PubMed
- Clin Chem. 1980 Dec;26(13):1775-9 - PubMed
- World J Gastroenterol. 2014 Oct 28;20(40):14672-85 - PubMed
- Steroids. 2013 Nov;78(11):1098-102 - PubMed
- Free Radic Biol Med. 1999 Oct;27(7-8):873-81 - PubMed
- Arch Pharm Res. 2011 May;34(5):767-74 - PubMed
- Fortschr Med. 1982 May 13;100(18):842-5 - PubMed
- Chem Cent J. 2012 Jul 31;6(1):76 - PubMed
- J Asian Nat Prod Res. 2013 Jul;15(7):708-16 - PubMed
- J Hepatol. 1991 Nov;13(3):372-4 - PubMed
- Clin Chem. 1973 Mar;19(3):338-40 - PubMed
- Acta Pol Pharm. 2012 Mar-Apr;69(2):171-7 - PubMed
- J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):31-9 - PubMed
- Life Sci. 2006 Jan 11;78(7):713-8 - PubMed
- Molecules. 2013 Oct 17;18(10 ):12937-50 - PubMed
- N Engl J Med. 2006 Feb 16;354(7):731-9 - PubMed
- Indian J Pharm Sci. 2008 Mar-Apr;70(2):265-8 - PubMed
- Acta Pharmacol Sin. 2012 Oct;33(10 ):1260-70 - PubMed
- Biochimie. 1997 Nov;79(11):629-36 - PubMed
- J Endocrinol Invest. 2014 Sep;37(9):783-8 - PubMed
- J Ethnopharmacol. 2015 Jun 20;168:66-78 - PubMed
- BMC Pharmacol. 2005 Jan 31;5:2 - PubMed
- Pak J Pharm Sci. 2013 Jul;26(4):757-60 - PubMed
- J Food Sci Technol. 2011 Aug;48(4):412-22 - PubMed
- Am J Clin Pathol. 1957 Jul;28(1):56-63 - PubMed
- Fundam Clin Pharmacol. 2009 Apr;23 (2):179-88 - PubMed
- J Natl Cancer Inst. 1972 May;48(5):1393-401 - PubMed
- Fitoterapia. 2002 Dec;73(7-8):557-63 - PubMed
- Immunopharmacol Immunotoxicol. 2012 Feb;34(1):157-62 - PubMed
Publication Types